Treating the AML cell line THP1 with DFMO led to PARP, caspase 3, and caspase 7 cleavage indicative of the induction of cell death (101), Similarly DFMO treatment decreased proliferation of the CML cell line K562 (102). The gene discussed is CASP3; the disease is acute myeloid leukemia.